Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $9,094 | 7 | 49.0% |
| Food and Beverage | $6,418 | 559 | 34.6% |
| Travel and Lodging | $2,791 | 9 | 15.1% |
| Education | $240.06 | 6 | 1.3% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI PASTEUR INC. | $6,178 | 4 | $0 (2020) |
| PFIZER INC. | $4,753 | 148 | $0 (2022) |
| Eli Lilly and Company | $2,917 | 3 | $0 (2018) |
| Novo Nordisk Inc | $1,446 | 153 | $0 (2022) |
| ABBVIE INC. | $491.91 | 40 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $348.72 | 39 | $0 (2022) |
| Amgen Inc. | $301.85 | 17 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $264.01 | 15 | $0 (2021) |
| Merck Sharp & Dohme LLC | $254.66 | 35 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $189.80 | 20 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $949.99 | 66 | ABBVIE INC. ($224.45) |
| 2021 | $987.59 | 73 | AbbVie Inc. ($209.49) |
| 2020 | $5,418 | 71 | SANOFI PASTEUR INC. ($4,560) |
| 2019 | $2,997 | 86 | PFIZER INC. ($1,407) |
| 2018 | $4,780 | 111 | Eli Lilly and Company ($2,213) |
| 2017 | $3,411 | 174 | PFIZER INC. ($1,735) |
All Payment Transactions
581 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/14/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Diabetes Care | ||||||
| 08/26/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Diabetes | ||||||
| 08/23/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Obesity | ||||||
| 08/11/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Diabetes Care | ||||||
| 08/08/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Diabetes Care | ||||||
| 07/27/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.54 | General |
| Category: Cardiovascular | ||||||
| 07/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Diabetes | ||||||
| 07/20/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.11 | General |
| Category: NEUROSCIENCE | ||||||
| 07/05/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Neuroscience | ||||||
| 06/27/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $11.50 | General |
| 06/22/2022 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: IMMUNOLOGY | ||||||
| 06/15/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Cardio-renal | ||||||
| 06/08/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Gastroenterology | ||||||
| 06/08/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Gastroenterology | ||||||
| 06/07/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Neuroscience | ||||||
| 06/06/2022 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Diabetes Care | ||||||
| 05/31/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Diabetes | ||||||
| 05/26/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Obesity | ||||||
| 05/19/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Neuroscience | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older | SANOFI PASTEUR INC. | $4,560 | 2 |
| A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LY2951742 IN PATIENTS WITH CHRONIC MIGRAINE - THE REGAIN STUDY | Eli Lilly and Company | $2,659 | 2 |
| Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT): A Phase III, Randomized, Double-blind, Non-inferiority Trial in Individuals 56 Years of Age and Older | SANOFI PASTEUR INC. | $1,617 | 2 |
| A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LY2951742 IN PATIENTS WITH EPISODIC MIGRAINE - THE EVOLVE-2 STUDY | Eli Lilly and Company | $257.60 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 9 | 701 | 1,003 | $91,295 | $41,771 |
| 2021 | 15 | 1,055 | 1,867 | $145,622 | $76,669 |
| 2020 | 16 | 1,224 | 2,111 | $165,702 | $71,876 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 236 | $40,250 | $16,104 | 40.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 86 | 86 | $14,620 | $10,812 | 74.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 189 | $24,405 | $10,350 | 42.4% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 12 | 12 | $2,030 | $1,583 | 78.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 25 | 29 | $1,450 | $984.32 | 67.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 197 | 323 | $5,005 | $957.03 | 19.1% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 25 | 27 | $1,890 | $463.62 | 24.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $325.00 | $321.50 | 98.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 83 | 88 | $1,320 | $195.98 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 181 | 400 | $66,000 | $34,184 | 51.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 116 | 252 | $30,240 | $15,274 | 50.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 119 | 119 | $20,230 | $15,071 | 74.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 54 | 54 | $3,399 | $3,383 | 99.5% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 20 | 20 | $2,800 | $2,500 | 89.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 240 | 523 | $7,845 | $1,565 | 19.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 57 | 57 | $1,368 | $906.75 | 66.3% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 22 | 25 | $1,250 | $883.25 | 70.7% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 33 | 40 | $2,800 | $839.65 | 30.0% |
| 85610 | Blood test, clotting time | Office | 2021 | 12 | 111 | $2,220 | $476.19 | 21.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 15 | 51 | $2,550 | $471.18 | 18.5% |
| 81003 | Automated urinalysis test | Office | 2021 | 136 | 163 | $2,445 | $361.86 | 14.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 20 | 20 | $500.00 | $319.03 | 63.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 19 | 21 | $1,260 | $225.80 | 17.9% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2021 | 11 | 11 | $715.00 | $207.92 | 29.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 211 | 470 | $77,550 | $32,155 | 41.5% |
About Dr. Timothy Koehler, D.O
Dr. Timothy Koehler, D.O is a Family Medicine healthcare provider based in Wichita, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1871596684.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Koehler, D.O has received a total of $18,544 in payments from pharmaceutical and medical device companies, with $949.99 received in 2022. These payments were reported across 581 transactions from 33 companies. The most common payment nature is "" ($9,094).
As a Medicare-enrolled provider, Koehler has provided services to 2,980 Medicare beneficiaries, totaling 4,981 services with total Medicare billing of $190,316. Data is available for 3 years (2020–2022), covering 40 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Wichita, KS
- Active Since 05/24/2005
- Last Updated 07/09/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1871596684
Products in Payments
- MENQUADFI (Biological) $3,740
- PREVNAR - 13 (Biological) $2,493
- TRUMENBA (Biological) $1,456
- MENACYW CONJUGATE VACCINE (Drug) $1,130
- NO PRODUCT DISCUSSED (Drug) $487.00
- Ozempic (Drug) $448.09
- Saxenda (Drug) $430.60
- CHANTIX (Drug) $393.58
- Aimovig (Biological) $301.85
- XARELTO (Drug) $257.99
- Victoza (Drug) $246.52
- SPIRIVA RESPIMAT (Drug) $197.77
- LYRICA (Drug) $196.48
- TROKENDI XR (Drug) $161.76
- Trintellix (Drug) $147.18
- VRAYLAR (Drug) $143.09
- QULIPTA (Drug) $124.97
- JANUVIA (Drug) $124.62
- Tresiba (Drug) $117.36
- VIAGRA (Drug) $115.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Wichita
Dr. Mila Means, M.d, M.D
Family Medicine — Payments: $248,802
Cole Gillenwater, M.d, M.D
Family Medicine — Payments: $53,886
Dr. Richard Egelhof, M.d, M.D
Family Medicine — Payments: $38,988
Dr. Hai Truong, D.o, D.O
Family Medicine — Payments: $31,271
Deborah Outwater, M.d, M.D
Family Medicine — Payments: $28,643
Dr. Tara Neil, Md, MD
Family Medicine — Payments: $24,299